Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Sleep dysregulation in binge eating disorder and “food addiction”: the orexin (hypocretin) system as a potential neurobiological link
Jacqueline B. Mehr, Deborah Mitchison, Hannah E. Bowrey, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 12, pp. 2051-2061
Open Access | Times Cited: 46
Orexin Reserve: A Mechanistic Framework for the Role of Orexins (Hypocretins) in Addiction
Morgan H. James, Gary Aston‐Jones
Biological Psychiatry (2022) Vol. 92, Iss. 11, pp. 836-844
Open Access | Times Cited: 33
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance study
Yu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety (2025)
Closed Access
Orexin receptors: possible therapeutic targets for psychiatric disorders
Shigeyuki Chaki
Psychopharmacology (2025)
Closed Access
The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act
Margaret Moline, Shoji Asakura, Carsten Beuckman, et al.
Psychopharmacology (2023) Vol. 240, Iss. 4, pp. 699-711
Open Access | Times Cited: 11
New directions in modelling dysregulated reward seeking for food and drugs
Robyn M. Brown, Christopher V. Dayas, Morgan H. James, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1037-1048
Open Access | Times Cited: 23
Physiological Role of Orexin/Hypocretin in the Human Body in Motivated Behavior: A Comprehensive Review
Rahul Singh, Dalia Biswas
Cureus (2023)
Open Access | Times Cited: 9
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Aida Mohammadkhani, Caitlin Mitchell, Morgan H. James, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 3
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 20
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking
Theresa E. Bjorness, Robert Greene
Pharmacology Biochemistry and Behavior (2021) Vol. 206, pp. 173194-173194
Open Access | Times Cited: 19
Sleep-mediated regulation of reward circuits: implications in substance use disorders
Rong Guo, Dylan T. Vaughan, Ana L. Almeida Rojo, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 61-78
Open Access | Times Cited: 12
Socially Integrated Polysubstance (SIP) system: An open-source solution for continuous monitoring of polysubstance fluid intake in group housed mice
Katrina Wong, Ziheng Christina Wang, Makenzie Patarino, et al.
Addiction Neuroscience (2023) Vol. 7, pp. 100101-100101
Open Access | Times Cited: 6
Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats
Kayla J. Colvin, Henry S. Killen, Maxwell J. Kanter, et al.
Behavioural Brain Research (2021) Vol. 421, pp. 113726-113726
Closed Access | Times Cited: 14
The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats
Shayna L. O’Connor, Gary Aston‐Jones, Morgan H. James
Neuropharmacology (2021) Vol. 195, pp. 108566-108566
Open Access | Times Cited: 13
Opiate anticipation, opiate induced anatomical changes in hypocretin (Hcrt, orexin) neurons and opiate induced microglial activation are blocked by the dual Hcrt receptor antagonist suvorexant, while opiate analgesia is maintained
R. L. McGregor, Ming‐Fung Wu, Thomas C. Thannickal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
Courtney S. Wilkinson, Harrison L. Blount, Shane Davis, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Anandamide improves food intake and orexinergic neuronal activity in the chronic sleep deprivation induction model in rats by modulating the expression of the CB1 receptor in the lateral hypothalamus
Rafie Belali, Seyyed Ali Mard, Seyed Esmaeil Khoshnam, et al.
Neuropeptides (2023) Vol. 101, pp. 102336-102336
Closed Access | Times Cited: 4
Machine Learning Models to Predict Ligand Binding Affinity for the Orexin 1 Receptor
Vanessa Zhang, Shayna L. O’Connor, William J. Welsh, et al.
Artificial Intelligence Chemistry (2023) Vol. 2, Iss. 1, pp. 100040-100040
Open Access | Times Cited: 4
Substance abuse and neurotransmission
Sarah E. Davis, Jun Zhu
Advances in pharmacology (2022), pp. 403-441
Open Access | Times Cited: 5
Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant
Manish K. Jha
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 85-88
Open Access | Times Cited: 6
Factors Associated with Prescriptions for an Orexin Receptor Antagonist Among Japanese Patients with Insomnia: Analysis of a Nationwide Japanese Claims Database
Shoki Okuda, Zaina P. Qureshi, Yukiko Yanagida, et al.
Drugs - Real World Outcomes (2023) Vol. 10, Iss. 2, pp. 271-281
Open Access | Times Cited: 2
Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking
Courtney S. Wilkinson, Harrison L. Blount, Shane Davis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
In vivo microdialysis reveals that blockade of accumbal orexin OX2 but not OX1 receptors enhances dopamine efflux in the nucleus accumbens of freely moving rats
Hiroki Kawashima, Yuri Aono, Yuriko Watanabe, et al.
European Journal of Neuroscience (2022) Vol. 55, Iss. 3, pp. 733-745
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top